Deciphering the role of circulating lncRNAs: RNCR2, NEAT2, CDKN2B-AS1, and PVT1 and the possible prediction of anti-VEGF treatment outcomes in diabetic retinopathy patients
- 55 Downloads
Putative roles of long non-coding RNAs (lncRNAs) as indicators for diabetic retinopathy (DR) and associated complications are beginning to emerge. We aimed to evaluate a panel of circulating hyperglycemia-related lncRNAs: RNCR2, NEAT2, CDKN2B-AS1, and PVT1 in type 2 diabetes patients with/without DR and to correlate their levels with the clinical characteristics and response to aflibercept intravitreal injection in terms of visual acuity (VA) improvement, central macular thickness (CMT) decline, and macular edema resolution after 4 weeks of the initial injection.
Pre-treatment plasma relative expression levels of the specified lncRNAs were quantified in 130 consecutive patients with diabetes (75 and 55 with/without DR, respectively) and 108 controls using quantitative real-time PCR.
One month after aflibercept injection, significant reductions in CMT and VA were observed in DR cohorts. The four lncRNAs were over-expressed in DM compared with those in controls. However, downregulated baseline plasma levels of RNCR2 and NEAT2 were observed in glycemic-controlled DR patients. None of the lncRNAs showed a correlation with the severity of retinopathy or drug response.
Though circulating levels of the analyzed lncRNAs did not show an association with DR progression or aflibercept therapy response, the expression pattern demonstrated good diagnostic performance in differentiating DM from controls and DR.
KeywordsAnti-VEGF Biomarker Diabetic retinopathy Gene expression Long non-coding RNAs RNCR2 NEAT2 CDKN2B-AS1 PVT1 qRT-PCR
The authors thank the Center of Excellence in Molecular and Cellular Medicine and the Oncology Diagnostic Unit, Suez Canal University, Ismailia, Egypt, for providing the facilities for performing the molecular work of the current study. The authors also thank all the participants for their approval to join this study.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 5.Tremolada G, Del Turco C, Lattanzio R, Maestroni S, Maestroni A, Bandello F, Zerbini G (2012) The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment. Exp Diabetes Res 2012:728325. https://doi.org/10.1155/2012/728325 CrossRefGoogle Scholar
- 8.Cabral T, Mello LGM, Lima LH, Polido J, Regatieri CV, Belfort R Jr, Mahajan VB (2017) Retinal and choroidal angiogenesis: a review of new targets. Int J Retina Vitreous 3(31). https://doi.org/10.1186/s40942-017-0084-9
- 10.Gong Q, Su G (2017) Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy. Biosci Rep 37. pii: BSR20171157. https://doi.org/10.1042/BSR20171157
- 12.Sathishkumar C, Prabu P, Mohan V, Balasubramanyam M (2018) Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes. Hum Genomics 12(41). https://doi.org/10.1186/s40246-018-0173-3
- 13.Raut SK, Khullar M (2018) The big entity of new RNA world: long non-coding RNAs in microvascular complications of diabetes. Front Endocrinol (Lausanne) 9(300). https://doi.org/10.3389/fendo.2018.00300
- 14.Fawzy MS, Abu AlSel BT, Al Ageeli E, Al-Qahtani SA, Abdel-Daim MM, Toraih EA (2018) Long non-coding RNA MALAT1 and microRNA-499a expression profiles in diabetic ESRD patients undergoing dialysis: a preliminary cross-sectional analysis. Arch Physiol Biochem 29:1–11. https://doi.org/10.1080/13813455.2018.1499119 CrossRefGoogle Scholar
- 21.Michalik KM, You X, Manavski Y, Doddaballapur A, Zörnig M, Braun T, John D, Ponomareva Y, Chen W, Uchida S, Boon RA, Dimmeler S (2014) Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res 114:1389–1397. https://doi.org/10.1161/CIRCRESAHA.114.303265 CrossRefGoogle Scholar
- 22.Congrains A, Kamide K, Ohishi M, Rakugi H (2013) ANRIL: Molecular mechanisms and implications in human health. Int J Mol Sci 14:1278–1292. https://doi.org/10.3390/ijms14011278
- 23.Alvarez ML, Khosroheidari M, Eddy E, Kiefer J (2013) Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy. PLoS One 8:e77468. https://doi.org/10.1371/journal.pone.0077468 CrossRefGoogle Scholar
- 26.Fawzy MS, Toraih EA, Abdallah HY (2017) Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1): a molecular predictor of poor survival in glioblastoma multiforme in Egyptian patients. Egyptian Journal of Medical Human Genetics 18:231–239. https://doi.org/10.1016/j.ejmhg.2016.08.003 CrossRefGoogle Scholar
- 28.Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611-622. https://doi.org/10.1373/clinchem.2008.112797
- 31.Leasher JL, Bourne RRA, Flaxman SR, Jonas JB, Keeffe J, Naidoo N, Pesudovs K, Price H, White RA, Wong TY, Resnikoff S, Taylor HR (2010) Vision Loss Expert Group of the Global Burden of Disease Study (2016) global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to. Diabetes Care 39:1643–1649. https://doi.org/10.2337/dc15-2171 CrossRefGoogle Scholar
- 39.Toraih EA, El-Wazir A, Alghamdi SA, Alhazmi AS, El-Wazir M, Abdel-Daim MM, Fawzy MS (2019) Association of long non-coding RNA MIAT and MALAT1 expression profiles in peripheral blood of coronary artery disease patients with previous cardiac events. Genet Mol Biol. https://doi.org/10.1590/1678-4685-GMB-2018-0185
- 40.Li Q, Pang L, Yang W, Liu X, Su G, Dong Y (2018) Long non-coding RNA of myocardial infarction associated transcript (LncRNA-MIAT) promotes diabetic retinopathy by upregulating transforming growth factor-β1 (TGF-β1) signaling. Med Sci Monit 24:9497–9503. https://doi.org/10.12659/MSM.911787 CrossRefGoogle Scholar
- 43.Li X, Zeng L, Cao C, Lu C, Lian W, Han J, Zhang X, Zhang J, Tang T, Li M (2017) Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy. Exp Cell Res 350:327–335. https://doi.org/10.1016/j.yexcr.2016.12.006 CrossRefGoogle Scholar
- 47.de Gonzalo-Calvo D, Kenneweg F, Bang C, Toro R, van der Meer RW, Rijzewijk LJ, Smit JW, Lamb HJ, Llorente-Cortes V, Thum T (2016) Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes. Sci Rep 6:37354. https://doi.org/10.1038/srep37354 CrossRefGoogle Scholar
- 49.Biswas S, Thomas AA, Chen S, Aref-Eshghi E, Feng B, Gonder J, Sadikovic B, Chakrabarti S (2018) MALAT1: an epigenetic regulator of inflammation in diabetic retinopathy. Sci Rep 8(6526). https://doi.org/10.1038/s41598-018-24907-w
- 54.Gupta A, Delhiwala KS, Raman RP, Sharma T, Srinivasan S, Kulothungan V (2016) Failure to initiate early insulin therapy - a risk factor for diabetic retinopathy in insulin users with type 2 diabetes mellitus: Sankara Nethralaya-diabetic retinopathy epidemiology and molecular genetics study (SN-DREAMS, report number 35). Indian J Ophthalmol 64:440–445. https://doi.org/10.4103/0301-4738.187668 CrossRefGoogle Scholar
- 55.Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R, Berliner AJ, Gao B, Zeitz O, Ruckert R, Schmelter T, Sandbrink R, Heier JS (2012) One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology 119:1658–1665. https://doi.org/10.1016/j.ophtha.2012.02.010 CrossRefGoogle Scholar
- 56.Nguyen CL, Lindsay A, Wong E, Chilov M (2018) Aflibercept for diabetic macular oedema: a meta-analysis of randomized controlled trials. Int J Ophthalmol 11:1002–1008Google Scholar